Invesaro

Stocks Health care ARAY

NASDAQ · Health care

Accuray Inc (ARAY)

Accuray Inc reported revenue of $401.9M in fiscal 2026, down 12.3% from a year earlier. It posted a net loss of $49.2M. In fiscal 2026 capital spending exceeded operating cash flow by $12.8M. At June 30, 2026 it held $40.6M in cash against $147.9M of debt. Its latest periodic report to the SEC is the annual report (10-K) filed on August 27, 2026.

Free, no password. An email when ARAY files with the SEC.

Price
$3.82
-13.18% on the day · November 9, 2026
52-week range $0.11 to $4.05
Market cap
$456.3M
Revenue (FY2026)
$401.9M
-12.3% year on year
Net margin
-12.2%

Key facts about Accuray Inc

Net worth
Accuray Inc has a market value (market cap) of $456.3M at the latest share price, and shareholders' equity of $41.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $401.9M (-12.3% year on year), with a net loss of $49.2M.
Cash flow
In fiscal 2026 operations used $7M of cash.
Latest report
The latest periodic report (annual report, 10-K) was filed with the SEC on August 27, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Accuray Inc's next report is expected around December 2, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Accuray Inc does

Accuray Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ARAY.

Revenue and profit by year

Revenue
FY19: $418.8M $418.8M FY19FY20: $382.9M $382.9M FY20FY21: $396.3M $396.3M FY21FY22: $429.9M $429.9M FY22FY23: $447.6M $447.6M FY23FY24: $446.6M $446.6M FY24FY25: $458.5M $458.5M FY25FY26: $401.9M $401.9M FY26
Net income
FY19: -$16.4M -$16.4M FY19FY20: $3.8M $3.8M FY20FY21: -$6.3M -$6.3M FY21FY22: -$5.3M -$5.3M FY22FY23: -$9.3M -$9.3M FY23FY24: -$15.5M -$15.5M FY24FY25: -$1.6M -$1.6M FY25FY26: -$49.2M -$49.2M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$401.9M-$26.4M-$49.2M-$0.40-$12.8M
2025$458.5M$7.8M-$1.6M-$0.02-$1.4M
2024$446.6M$504K-$15.5M-$0.16-$15.5M
2023$447.6M$2.4M-$9.3M-$0.10$2.9M
2022$429.9M$8.1M-$5.3M-$0.06-$7.1M
2021$396.3M$22.2M-$6.3M-$0.07$36.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around December 2, 2026.

Estimated from its filing rhythm: about 105 days after its last report of August 19, 2026, its usual gap. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where ARAY ranks in Health care

Revenue$401.9M
#217 of 751 in Health care · Top 29%
Revenue growth-12.3%
#469 of 532 in Health care · Bottom 12%
Net margin-12.2%
#296 of 544 in Health care · Bottom 46%
Free cash flow margin-3.2%
#264 of 490 in Health care · Bottom 46%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Accuray Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 6, 2026
    Executive or director change8-KAccuray stockholders approved key financing proposals and the company appointed Richard A. Meier to its board of directors.
  2. September 18, 2026
  3. September 9, 2026
  4. September 2, 2026
  5. August 27, 2026
    Annual report 10-K · period to June 30, 2026Revenue fell 12% to $401.9M versus the prior year; diluted EPS -$0.40 versus -$0.02.
  6. August 24, 2026
  7. August 21, 2026
  8. August 19, 2026
  9. August 12, 2026
  10. August 6, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 1, 2026. Insider transactions on SEC

Insider trades

What the people running Accuray Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 23, 2026 Pervaiz AliSVP Chief Financial Officer Received as pay 19,811 - - Form 4
September 23, 2026 Pervaiz AliSVP Chief Financial Officer Shares withheld for tax 8,915 $0.23 $2K Form 4
March 31, 2026 Chalke SandeepSVP, Chief Commercial Officer Shares withheld for tax 40,000 $0.39 $15.5K Form 4
February 28, 2026 Peralta LeonelSVP, Chief Operations Officer Exercised options 83,723 - - Form 4
February 28, 2026 Peralta LeonelSVP, Chief Operations Officer Shares withheld for tax 28,969 $0.55 $15.9K Form 4
February 20, 2026 Mayer Steven FDirector Bought 54,875 $0.56 $30.9K Form 4
February 19, 2026 Mayer Steven FDirector Bought 69,000 $0.53 $36.6K Form 4
February 18, 2026 Mayer Steven FDirector Bought 126,125 $0.53 $67.2K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ARAY

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
The TCW Group, Inc., on behalf of the TCW Business Unit13D, may seek influence 18.7% 27,527,916 September 2, 2026

Latest filings below 5%: Neuberger Berman Group LLC 4.6% (August 5, 2026); The Vanguard Group 0% (March 26, 2026); Aevum Pension Fund 4.9% (October 2, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 111 managers reported a position.

HolderSharesValueChange on quarter
Tcw Group Inc18,942,059$4.1M+3,474,107
Neuberger Berman Group LLC6,073,663$1.6M+218,599
Armistice Capital, LLC5,736,000$1.5M+100,000
Weber Capital Management LLC4,932,706$1.3M-122,588
Vanguard Capital Management LLC4,437,800$1.1M+7,408
BlackRock, Inc.3,266,185$842K-5,192,224
Aqr Capital Management LLC2,719,032$701K+2,101,555
Jane Street Group, LLC2,139,720$551.6Knew
Renaissance Technologies LLC2,065,284$532.4K-225,700
DAFNA Capital Management LLC1,680,508$433.2K0
UBS Group AG1,623,965$419K+222,199
Millennium Management LLC1,589,145$409.7Knew
Silverback Asset Management LLC1,450,000$373.8K-200,000
Squarepoint Ops LLC1,448,234$373.4K+901,158
Fmr LLC1,375,746$354.7K+86,958
Geode Capital Management, LLC1,189,377$306.7K-1,191,462
Kovack Advisors, Inc.1,050,896$272.7K+312,800
Susquehanna International Group, Llp825,604$212.8K+791,827
Goldman Sachs Group Inc802,957$207K-58,678
Vanguard Fiduciary Trust Co685,262$176.8K-80,186

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

13 insiders reported holding 4,434,142 shares in total, about $16.9M at the last price.

HolderSharesAs of
Mayer Steven FDirector 1,545,620 February 20, 2026
Whitters Joseph EDirector 667,656 November 21, 2025
Chalke SandeepSVP, Chief Commercial Officer 419,806 March 31, 2026
Pervaiz AliSVP Chief Financial Officer 366,259 September 23, 2026
Hindman James M.Director 294,804 November 21, 2025
Le Grand Anne BryceDirector 259,499 November 21, 2025
Huss Beverly ADirector 221,323 November 21, 2025
Nishimura MikaDirector 212,659 November 21, 2025
Kill RobertDirector 162,809 November 13, 2025
Scott Byron CDirector 158,953 December 31, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ARAY

What does Accuray Inc do?

Accuray Inc is a company in the Health care sector, listed on NASDAQ as ARAY. Its shares trade on NASDAQ under the ticker ARAY.

What is Accuray Inc's net worth?

Accuray Inc has a market value (market cap) of $456.3M at the latest share price, and shareholders' equity of $41.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Accuray Inc profitable?

No. In fiscal 2026 it reported a net loss of $49.2M on revenue of $401.9M.

How much revenue does Accuray Inc make?

In fiscal 2026 Accuray Inc reported revenue of $401.9M. That is 12.3% less than a year earlier.

When did Accuray Inc last report?

Its most recent periodic report is the annual report (10-K) filed on August 27, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from October 6, 2026.

When is Accuray Inc's next earnings report?

Accuray Inc's next report is expected around December 2, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare ARAY with

Compare ARAY with any company

Follow ARAY

Get an email when Accuray Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ARAY files with the SEC.

Where the numbers come from

Financial figures are the values Accuray Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.